Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goreisan for migraine with comorbid psychiatric disorders
jRCT1031260604Completed
- Sponsor
- SUSUMU HIROTA
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oreongsan in migraine, sponsored by SUSUMU HIROTA. Primary endpoint: Change in headache Numeric Rating Scale (NRS) score. Started Oct 2026; status: completed.
02
Drugs
oreongsan
03
Conditions
migraine
Beyond the preview
Go deeper on jRCT1031260604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031260604.